These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 9673808

  • 1. How does sumatriptan nasal spray perform in clinical practice?
    Dahlöf CG, Boes-Hansen S, Cederberg CG, Hardebo JE, Henriksson A.
    Cephalalgia; 1998 Jun; 18(5):278-82. PubMed ID: 9673808
    [Abstract] [Full Text] [Related]

  • 2. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G, Valette C.
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [Abstract] [Full Text] [Related]

  • 3. Consistency of response to sumatriptan nasal spray across patient subgroups and migraine types.
    Ashford E, Salonen R, Saiers J, Woessner M.
    Cephalalgia; 1998 Jun; 18(5):273-7. PubMed ID: 9673807
    [Abstract] [Full Text] [Related]

  • 4. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies.
    Ryan R, Elkind A, Baker CC, Mullican W, DeBussey S, Asgharnejad M.
    Neurology; 1997 Nov; 49(5):1225-30. PubMed ID: 9371898
    [Abstract] [Full Text] [Related]

  • 5. Clinical applications of new therapeutic deliveries in migraine.
    Dahlöf C.
    Neurology; 2003 Oct 28; 61(8 Suppl 4):S31-4. PubMed ID: 14581656
    [Abstract] [Full Text] [Related]

  • 6. Sumatriptan: pharmacological basis and clinical results.
    Dahlöf CG.
    Curr Med Res Opin; 2001 Oct 28; 17 Suppl 1():s35-45. PubMed ID: 12463276
    [Abstract] [Full Text] [Related]

  • 7. Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine.
    Diamond S, Elkind A, Jackson RT, Ryan R, DeBussey S, Asgharnejad M.
    Arch Fam Med; 1998 Oct 28; 7(3):234-40. PubMed ID: 9596457
    [Abstract] [Full Text] [Related]

  • 8. Parental satisfaction with sumatriptan nasal spray in childhood migraine.
    Pakalnis A, Kring D, Paolicchi J.
    J Child Neurol; 2003 Nov 28; 18(11):772-5. PubMed ID: 14696905
    [Abstract] [Full Text] [Related]

  • 9. An open-label study to assess changes in efficacy and satisfaction with migraine care when patients have access to multiple sumatriptan succinate formulations.
    Weidmann E, Unger J, Blair S, Friesen C, Hart C, Cady R.
    Clin Ther; 2003 Jan 28; 25(1):235-46. PubMed ID: 12637123
    [Abstract] [Full Text] [Related]

  • 10. Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.
    Natarajan S, Jabbour JT, Webster CJ, Richardson MS.
    Headache; 2004 Jan 28; 44(10):969-77. PubMed ID: 15546259
    [Abstract] [Full Text] [Related]

  • 11. Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies.
    Dahlöf C.
    Cephalalgia; 1999 Nov 28; 19(9):769-78. PubMed ID: 10595285
    [Abstract] [Full Text] [Related]

  • 12. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
    Dowson AJ, Charlesworth BR, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.
    CNS Drugs; 2003 Nov 28; 17(11):839-51. PubMed ID: 12921494
    [Abstract] [Full Text] [Related]

  • 13. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
    Dodick D, Brandes J, Elkind A, Mathew N, Rodichok L.
    CNS Drugs; 2005 Nov 28; 19(2):125-36. PubMed ID: 15697326
    [Abstract] [Full Text] [Related]

  • 14. A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine.
    Touchon J, Bertin L, Pilgrim AJ, Ashford E, Bès A.
    Neurology; 1996 Aug 28; 47(2):361-5. PubMed ID: 8757005
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Butterscotch masks the bitter taste of sumatriptan nasal spray.
    Blumenthal HJ.
    Headache; 2001 Feb 28; 41(2):210. PubMed ID: 11251713
    [No Abstract] [Full Text] [Related]

  • 17. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine.
    Loder E, Brandes JL, Silberstein S, Skobieranda F, Bohidar N, Wang L, Boyle D, Kolodny A, Guerra F, Santanello N, Johnson-Pratt L, Rizatriptan Protocol 060 Study Group.
    Headache; 2001 Sep 28; 41(8):745-53. PubMed ID: 11576197
    [Abstract] [Full Text] [Related]

  • 18. Nasal sumatriptan is effective in treatment of migraine attacks in children: A randomized trial.
    Ahonen K, Hämäläinen ML, Rantala H, Hoppu K.
    Neurology; 2004 Mar 23; 62(6):883-7. PubMed ID: 15037686
    [Abstract] [Full Text] [Related]

  • 19. Sumatriptan. An updated review of its use in migraine.
    Perry CM, Markham A.
    Drugs; 1998 Jun 23; 55(6):889-922. PubMed ID: 9617601
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of nasal sumatriptan in 5- to 12-year-old children.
    Hershey AD, Powers SW, LeCates S, Bentti AL.
    Headache; 2001 Jun 23; 41(7):693-7. PubMed ID: 11554957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.